Evaluation of the Possibility to Delegate Glaucoma Surveillance to Orthoptists in Hospital

NCT ID: NCT02876185

Last Updated: 2024-10-21

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 133 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2016-04-08
• Study Completion Date: 2023-05-05

Brief Summary

Glaucoma is a progressive optical neuropathy, generally associated with ocular hypertension. The treatment aims to stabilize the visual field deficiencies by lowering the intraocular pressure. Due to the fluctuation of the visual field test and re-test measures, the European recommendations are to obtain 6 visual field tests in 2 years (or one every 4 months) in order to know if the pathology is progressing despite the current treatment (or if the treatment is necessary, in cases of intraocular hypertensions). The lack of ophthalmologists renders the monitoring of a beginning glaucoma, rarely compatible with the present recommendations. It is therefore crucial to evaluate new therapeutic alternatives, when faced to a decreasing medical demography and an increase the patient's needs.

This study should allow to validate the possibility to delegate monitoring tasks to orthoptists during glaucoma surveillance. To organize the delegation of this surveillance to orthoptists would permit a better distribution of the ophthalmologist's activities.

Conditions

Glaucoma

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Patients with glaucoma

Patients presenting an open-angle glaucoma or ocular hypertension

Monitoring by an orthoptist then by an ophthalmologist

Intervention Type: OTHER

At each visit, the usual monitoring tests will be collected and viewed by the orthoptist then by the ophthalmologist concerning the necessity of an anticipated ophthalmological consultation

Interventions

Monitoring by an orthoptist then by an ophthalmologist

At each visit, the usual monitoring tests will be collected and viewed by the orthoptist then by the ophthalmologist concerning the necessity of an anticipated ophthalmological consultation

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Age from 18 years old or more
• Open-angle glaucoma or ocular hypertension

Exclusion Criteria

• Other active ocular pathology
• Monophthalmic patients
• Patients requiring a Goldmann visual field exam
• Opposition of the patient to participate to the trial
• Pregnant women or breastfeeding
• Patient under juridical protection
• Lack of affiliation to social security or universal health coverage

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Centre hospitalier

Angers, , France

Hôpital Ambroise-Paré

Boulogne-Billancourt, , France

Clinique Universitaire d'Ophtalmologie

Grenoble, , France

Fondation Ophtalmologique A de Rothschild

Paris, , France

Countries

France

Other Identifiers

ICU_2015_39

Identifier Type: -

Identifier Source: org_study_id